Metabolomic Profiling of Erector Spinae Plane Block* for Breast Cancer Surgery

CompletedOBSERVATIONAL
Enrollment

91

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

May 1, 2021

Study Completion Date

October 1, 2021

Conditions
Breast Cancer
Interventions
DRUG

Morphine

"PREOPERATIVE ANALGESIA: None~INTRAOPERATİVE ANALGESIA:~1. Paracetamol 1000 mg IV~2. Morphine 0,1 mg/kg IV~POSTOPERATIVE ANALGESIA IV Morphine Patient-Controlled Analgesia (PCA) Rescue analgesic: IV paracetamol"

PROCEDURE

Erector Spinae Block

"PREOPERATIVE ANALGESIA:~Ultrasonography (USG) guided ESP block:T4 spinal level, %0,25 concentration 20 ml, single injection~INTRAOPERATİVE ANALGESIA:~1. Paracetamol 1000 mg IV~2. dexketoprofen 50 mg IV~POSTOPERATIVE ANALGESIA IV PCA with tramadol Rescue analgesic: IV paracetamol"

DRUG

Control

"PREOPERATIVE ANALGESIA: none~INTRAOPERATİVE ANALGESIA:~1. Paracetamol 1000 mg IV~2. Dexketoprofen 50 mg IV~POSTOPERATIVE ANALGESIA IV PCA with tramadol Rescue analgesic: IV paracetamol"

Trial Locations (1)

06200

Dr.Abdurrahman Yurtaslan Ankara Oncology Train and Research Hospital, Ankara

All Listed Sponsors
lead

Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital

OTHER

NCT04689945 - Metabolomic Profiling of Erector Spinae Plane Block* for Breast Cancer Surgery | Biotech Hunter | Biotech Hunter